Trevena (TRVN) - Shares outstanding

Number of shares outstanding as of December 2025 : 852,801

According to Trevena's latest financial reports and stock price the company's current number of shares outstanding is 852,801. At the end of 2024 the company had 852,801 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Trevena from 2024 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.85 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Amgen AMGN	538,000,000	62,986.23%	🇺🇸 USA
Cytokinetics CYTK	119,982,000	13,969.17%	🇺🇸 USA
Cara Therapeutics CARA	4,562,738	435.03%	🇺🇸 USA
Merck MRK	2,487,348,810	291,568.14%	🇺🇸 USA
Arena Pharmaceuticals ARNA	56,662,000	6,544.22%	🇺🇸 USA
AcelRx Pharmaceuticals ACRX	16,758,322	1,865.09%	🇺🇸 USA
Flexion Therapeutics FLXN	38,562,800	4,421.90%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Trevena (TRVN)

Number of shares outstanding as of December 2025 : 852,801